News & Events

The Rondol team was really glad to attend the Dow Solubility Symposium 2016 in Zurich on April 27^th (http://www.pharma-excipients.ch/2016/04/01/solubility-symposium/) .

The number and level of participants clearly highlighted the growing interest of the pharma industry in the Hot Melt Extrusion (HME) technology.

It was a great opportunity for all industry actors to listen, meet and exchange about further developments of polymer solutions for the pharma industry facing solubility challenges.

Prof. Victoire de Margerie, Rondol President states: “We are convinced that our new vertical micro extruder is the best machine for processing the full range of Dow’s AFFINISOL™ polymers. On top of the usual advantages of all existing micro extruders, it offers specific advantages for Pharma applications thanks to its smaller footprint (0,5m² vs 2,5m² for an horizontal one), its efficient temperature control (cooling on all 8 barrel zones), easy scalability and a very user friendly monitoring software.

And Dr. Michael Baumann, Pharma Field Marketing Manager EMEA for Dow Pharma & Food Solutions states: "it is crucial that machine and polymer producers collaborate in order to offer the most competitive and high quality solutions to our pharma customers. We will be happy to include Rondol as one of our value chain partners, and develop the best extrusion settings for processing AFFINISOL™ based compounds."

For more information, feel free to email us at: donatien@rondol.com